edaravone has been researched along with Atrophy in 2 studies
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral montelukast (0." | 1.37 | Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. ( Fang, SH; Shi, WZ; Wei, EQ; Zhang, YM; Zhao, R, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohta, Y | 1 |
| Nomura, E | 1 |
| Shang, J | 1 |
| Feng, T | 1 |
| Huang, Y | 1 |
| Liu, X | 1 |
| Shi, X | 1 |
| Nakano, Y | 1 |
| Hishikawa, N | 1 |
| Sato, K | 1 |
| Takemoto, M | 1 |
| Yamashita, T | 1 |
| Abe, K | 1 |
| Zhao, R | 1 |
| Shi, WZ | 1 |
| Zhang, YM | 1 |
| Fang, SH | 1 |
| Wei, EQ | 1 |
2 other studies available for edaravone and Atrophy
| Article | Year |
|---|---|
Enhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Atrophy; Edaravone; Female; Histone Deacetylases; Humans; Lo | 2019 |
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats.
Topics: Acetates; Administration, Oral; Animals; Antipyrine; Atrophy; Behavior, Animal; Brain Injury, Chroni | 2011 |